Investec Bank Plc has filed a Form 8.5 public dealing disclosure relating to Advanced Medical Solutions Group Plc (AMS.L) under Rule 8.5 of the Takeover Code.
The disclosure covers transactions undertaken on 25th September 2026, with the filing itself dated 28th September 2026.
Investec Bank Plc holds a recognised intermediary status as an exempt principal trader, meaning it is required to publicly disclose dealings conducted in a client-serving capacity.
The bank serves as Advisor and Joint Broker to Advanced Medical Solutions Group Plc, establishing its direct connection to the offer party named in the disclosure.
During the dealing period, Investec purchased 13,140 ordinary shares in Advanced Medical Solutions Group at a price of 282.25 pence per unit.
The bank also recorded sales of 18,472 ordinary shares at the same price of 282.25 pence per unit on the same date.
No cash-settled derivative transactions, stock-settled derivative transactions, or options activity was reported as part of this disclosure filing.
Investec confirmed there are no indemnity arrangements, option agreements, or informal understandings in place that could serve as an inducement to deal or refrain from dealing.
The bank also confirmed no agreements exist relating to voting rights or future acquisition and disposal of relevant securities to which any derivative may be referenced.
The disclosure contact named in the filing is Abhishek Gawde, reachable by telephone at +91-9923757332 for any related enquiries.
Public disclosures of this nature under Rule 8 of the Takeover Code are required to be submitted to a Regulatory Information Service to ensure market transparency.
The Panel’s Market Surveillance Unit remains available for consultation on dealing disclosure requirements under the Code for any parties seeking guidance.
